Skip to content
Unrated Drug recall · FDA · Published March 25, 2026

Sun Pharmaceutical Fluocinonide Cream Recall: Failed Viscosity Testing

Sun Pharmaceutical Industries recalls 0.05% Fluocinonide cream due to failed viscosity tests. This may affect stability and product performance. Contact for details.

🇺🇸 FDA recall #D-0476-2026DrugSun Pharmaceutical Industries ›
Take action

Contact the company

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way · Princeton, NJ 08540-6620
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sun Pharmaceutical Industries is recalling 0.05% Fluocinonide cream tubes that failed viscosity testing during stability checks. This could lead to product instability, though serious injury risks are not specified in the recall. Read more at govinfonow.com/recall/31387-sun-pharmaceutical-fluocinonide-cream-recall-failed-viscosity-testing.

Source Summary by GovInfoNow · govinfonow.com/recall/31387-sun-pharmaceutical-fluocinonide-cream-recall-failed-viscosity-testing · Updated August 17, 2026 · FDA enforcement record: FDA #D-0476-2026

Cite this page

“Sun Pharmaceutical Fluocinonide Cream Recall: Failed Viscosity Testing.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31387-sun-pharmaceutical-fluocinonide-cream-recall-failed-viscosity-testing. Based on FDA recall #D-0476-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0476-2026%22&limit=1).

Why it’s dangerous

The cream failed viscosity tests during stability testing, meaning it may not maintain proper consistency over time. This could affect product performance but does not indicate immediate safety risks.

Who’s affected

Prescription users of the 0.05% Fluocinonide cream in 30g tubes. Those with the specific lot number AD76251 are most at risk.

How to tell if you have this one

Check for the product name 'Fluocinonide, USP, 0.05% Cream, 30g tube' with lot number AD76251. It was manufactured in Canada and distributed by Taro Pharmaceuticals U.S.A.

  • Brand
    Sun Pharmaceutical Industries
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide in the USA.
  • NDC
    51672-1386-1, 51672-1386-2, 51672-1386-3, 51672-1386-4
Recall numberProduct, codes & lotsQuantity
D-0475-2026Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-1; Lot# AD76252, Exp Date: 6/30/2026.24,672 15 g tubes
D-0476-2026Fluocinonide, USP, 0.05% Cream, 30g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-2.; Lot# AD76251, Exp Date: 6/30/2026.41,712 30g tubes
D-0477-2026Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-3.; Lot# AD76250, Exp Date: 6/30/2026.2,640 60g tubes
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number AD76251 on the tube label to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 28 days after the firm started it.

1. Firm started the recall: Mar 25, 202612. FDA classified it Class II: Apr 13, 202623. Published in FDA’s Enforcement Report: Apr 22, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sun Pharmaceutical Industries recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0476-2026 (March 25, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0476-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA